Our findings confirm those of previous studies, which have indicated that the predictors of T2D remission after either VLCD or MBS are a short duration of T2D, not currently taking insulin and a higher C-peptide level [48,49]. This evidence concerns the gene INS and type 2 diabetes mellitus.